(6-((tert-Butoxycarbonyl)amino)-5-methylpyridin-3-yl)boronic acid

Catalog No. :
ACWHAU963
CAS No. :
1356087-58-5
Molecular Formula :
C11H17BN2O4
Molecular Weight :
252.08

IUPAC Name:(6-((tert-butoxycarbonyl)amino)-5-methylpyridin-3-yl)boronic acid

(6-((tert-Butoxycarbonyl)amino)-5-methylpyridin-3-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$382.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-((tert-Butoxycarbonyl)amino)-5-methylpyridin-3-yl)boronic acid
IUPAC Name(6-((tert-butoxycarbonyl)amino)-5-methylpyridin-3-yl)boronic acid
MDL No.MFCD18262106
Molecular FormulaC11H17BN2O4
Molecular Weight252.08
SMILESCC1=C(NC(OC(C)(C)C)=O)N=CC(B(O)O)=C1
InChI KeyYEHXEJUMAMZEKC-UHFFFAOYSA-N
Synonym2-tert-ButyloxycarbonylaMino-3-Methylpyridine-5-boronic acid;[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]pyridin-3-yl]boronic acid;Carbamic acid, N-(5-borono-3-methyl-2-pyridinyl)-, C-(1,1-dimethylethyl) ester
CAS No.1356087-58-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACWHAU963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSGIA126 route compound structure diagram
    ACSGIA1261032759-01-5 In Stock
  4. Then
  5. ACWHAU963 route product structure diagram
    ACWHAU9631356087-58-5
Inquiry

2. ACWHAU963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWHAU963 route product structure diagram
    ACWHAU9631356087-58-5
Inquiry

Comments (0)